Research

(iStock image)

VUMC awarded $26.4 million for patient-centered research

The awards support research efforts to identify optimal approaches to improving health care and health outcomes for patients, families and the community.

Study uses AI to cast light on harmful drug-drug interactions

Using AI, a team identified a gap in post-market drug safety: not all published reports of dangerous drug interactions are taken up by recognized purveyors of drug safety information.

Vanderbilt joins national effort to develop alphavirus vaccines

The project aims to design computational “tool kits” that can speed development of multi-virus vaccines targeting some of the greatest infectious threats to human health.

Study identifies that higher West African ancestry may contribute to worse breast cancer outcomes 

The study found that West African genetic ancestry was associated with shorter disease-free survival, particularly for women with hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer.

Members of the Kang lab include (front row from left) Melissa Deleeuw, Jing-Qiong (Katty) Kang, MD, PhD, Wangzhen Shen, MD, and Karishma Randhave, and (back row from left) Ekta Anand, Debbie Song, and Kirill Zavalin, PhD. (photo by Susan Urmy)

Therapy for genetic epilepsy in children showing promise

Preliminary results of a clinical trial of 4-phenylbutyrate (PBA) “show a significant reduction in seizure activity among participants.”

(file photo by Anne Rayner)

VUMC to study effect of breathing tube size on breathing, speaking, swallowing

Approximately 1% of the U.S. population — 2 million to 3 million adults — experience critical illness requiring the placement of a breathing tube each year.

1 11 12 13 14 15 135